ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,018.39
      0.00%
      US Tech 100
      17,022.40
      0.96%
      Dow Jones
      37,903.29
      0.00%
      Brent Oil
      83.505
      -0.04%
      Bitcoin
      58,589.31
      0.60%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aerovate Therapeutics Inc (AVTE)

      7. Aerovate Therapeutics Inc (AVTE) News

      AVTE

      Aerovate Therapeutics (AVTE)

      Aerovate Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AVTE
      DateTimeSourceHeadlineSymbolCompany
      03/27/20249:20AMGlobeNewswire Inc.Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International ConferenceNASDAQ:AVTEAerovate Therapeutics Inc
      03/25/20244:10PMGlobeNewswire Inc.Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
      03/11/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      03/07/20244:37PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      03/06/20248:00AMGlobeNewswire Inc.Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board ChairNASDAQ:AVTEAerovate Therapeutics Inc
      02/27/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      02/22/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      02/20/20246:38PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      02/09/20244:28PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVTEAerovate Therapeutics Inc
      01/24/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      01/24/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      01/24/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      01/24/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      01/17/20244:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      01/08/20245:11PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVTEAerovate Therapeutics Inc
      01/08/20247:59AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTEAerovate Therapeutics Inc
      12/29/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      12/27/20235:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      12/22/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      12/20/20234:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      12/15/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      12/14/20234:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      12/07/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      11/29/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      11/27/20236:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      11/22/20234:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
      11/20/20234:46PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTEAerovate Therapeutics Inc
      11/20/20234:45PMGlobeNewswire Inc.Aerovate Therapeutics Announces Simultaneous Completion of Enrollment in Phase 2b Portion and Enrollment of First Patient into Phase 3 in the IMPAHCT Trial Evaluating AV-101 for the Treatment of Pulmonary Arterial HypertensionNASDAQ:AVTEAerovate Therapeutics Inc
      11/13/20238:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTEAerovate Therapeutics Inc
      11/13/20238:00AMGlobeNewswire Inc.Aerovate Therapeutics Announces Third Quarter Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:AVTE